eVenus Pharmaceutical Laboratories

FDA Regulatory Profile

eVenus Pharmaceutical Laboratories appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0042-2021, Class III) was initiated on October 6, 2020.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0042-2021Class IIIDesflurane, USP Liquid for Inhalation, 240 mL, Rx Only, Manufactured by: Shanghai Hengrui PharmaceuOctober 6, 2020